Atlas Trials

cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project

Clinical trial NCT01543113 · COMPLETED

Trial details

NCT number
NCT01543113
Sponsor
Rennes University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma
Start date
2011-01-01
Primary completion
2012-03-01
Enrollment
288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.